Zheng Quan Shi Bao Wang·2025-11-14 11:12Core Insights - JD Health's performance during the 11.11 shopping festival demonstrated significant growth, with over 2,500 health and nutrition brands achieving a doubling of transaction volume year-on-year, and nearly 100 subcategories also seeing a 100% increase in sales [1] - The company reported a strong third-quarter performance, with revenues reaching 17.12 billion yuan, a year-on-year increase of 28.7%, and a Non-IFRS net profit of 1.9 billion yuan, up 42.4% [1] - JD Health launched over 30 new specialty drugs during the reporting period, reinforcing its position as the leading platform for the online debut of new specialty drugs [1] Business Developments - At the recent China International Import Expo, JD Health established multiple partnerships with nine global nutrition and health brands, including Noromega and NYO3, to introduce high-quality products to the Chinese market [2] - The company has formed a professional nutritionist team to provide scientific nutritional knowledge through live broadcasts and online consultations, enhancing consumer understanding [2] - The AI nutritionist has been implemented to handle over 90% of online consultations during the 11.11 period, covering more than 200 nutrition categories and providing personalized advice based on user data [2] Future Outlook - JD Health's management emphasized the vast potential of the health consumption market, indicating plans to deepen the super supply chain layout and integrate global quality nutrition products with professional services [3] - The company aims to drive the nutrition and health industry towards standardization and precision, providing better health solutions for consumers and sustaining growth momentum [3]